Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein
Juanjuan Liu,Dongxu Cui,Yi Jiang,Yuyin Li,Zhenxing Liu,Li Tao,Qing Zhao,Aipo Diao
DOI: https://doi.org/10.1016/j.ijbiomac.2020.10.245
IF: 8.2
2021-01-01
International Journal of Biological Macromolecules
Abstract:Alpha-fetoprotein (AFP) is one of the most important biomarkers associated with primary liver cancer, and the main approaches for diagnosis are based on immunoassay. Affibody is a 58 amino acids peptide derived from the Z domain of staphylococcal protein A and generally applied in imaging diagnosis, clinical therapeutics and biotechnology research. The aim of this study was therefore to develop a novel affibody-based ELISA for detection of AFP. After three rounds of biopanning, six AFP-binding affibody peptides were selected using phage display technology, among them affibody Z<sub>AFPD2</sub> showed high and specific binding affinity to AFP. An affibody dimer of Z<sub>AFPD2</sub> was created, named (Z<sub>AFP D2</sub>)<sub>2</sub>, expressed in E.coli and the purified (Z<sub>AFP D2</sub>)<sub>2</sub> recombinant protein showed higher binding affinity to AFP, as well as high thermal stability. A novel affibody-based two-site ELISA method using Z<sub>AFPD2</sub> or (Z<sub>AFP D2</sub>)<sub>2</sub> and polyclonal antibody to detect AFP was developed, the detection limit of the immunoassay using (Z<sub>AFP D2</sub>)<sub>2</sub> was 2 ng mL<sup>-1</sup> that was 4 times lower than Z<sub>AFPD2</sub>, which meets the requirements for practical application. Therefore, this concept of affibody-based ELISA may provide a new method for the detection of various cancer biomarkers.
polymer science,biochemistry & molecular biology,chemistry, applied